Index S&P 500
P/E 30.68
EPS (ttm) 4.43
Insider Own 0.43%
Shs Outstand 285.19M
Perf Week 2.12%
Market Cap 38.79B
Forward P/E 22.24
EPS next Y 6.11
Insider Trans -1.50%
Shs Float 284.37M
Perf Month 1.00%
Income 1.29B
PEG 3.84
EPS next Q 1.27
Inst Own 91.12%
Short Float 1.11%
Perf Quarter -7.43%
Sales 6.51B
P/S 5.96
EPS this Y 5.15%
Inst Trans -1.24%
Short Ratio 1.80
Perf Half Y 3.85%
Book/sh 20.68
P/B 6.57
EPS next Y 9.79%
ROA 11.36%
Short Interest 3.15M
Perf Year -2.85%
Cash/sh 4.65
P/C 29.19
EPS next 5Y 8.00%
ROE 21.95%
52W Range 124.16 - 155.35
Perf YTD -2.30%
Dividend Est. 1.00 (0.73%)
P/FCF 28.25
EPS past 5Y 5.63%
ROI 13.73%
52W High -12.57%
Beta 1.07
Dividend TTM 0.94 (0.69%)
Quick Ratio 1.58
Sales past 5Y 5.04%
Gross Margin 54.72%
52W Low 9.40%
ATR (14) 2.96
Dividend Ex-Date Dec 31, 2024
Current Ratio 2.09
EPS Y/Y TTM 5.34%
Oper. Margin 24.52%
RSI (14) 48.11
Volatility 1.97% 2.38%
Employees 17900
Debt/Eq 0.61
Sales Y/Y TTM -4.73%
Profit Margin 19.80%
Recom 2.33
Target Price 149.07
Option/Short Yes / Yes
LT Debt/Eq 0.59
EPS Q/Q -24.56%
Payout 21.31%
Rel Volume 0.32
Prev Close 136.10
Sales Surprise 1.10%
EPS Surprise 3.54%
Sales Q/Q 0.77%
Earnings Nov 25 AMC
Avg Volume 1.75M
Price 135.83
SMA20 -1.64%
SMA50 0.29%
SMA200 -1.91%
Trades
Volume 556,476
Change -0.20%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-28-24 Initiated
Wells Fargo
Overweight
$157
Jul-10-24 Upgrade
Citigroup
Neutral → Buy
$135 → $150
Jun-27-24 Downgrade
Wolfe Research
Outperform → Peer Perform
Jun-03-24 Resumed
Jefferies
Hold
$135
Apr-05-24 Upgrade
Stifel
Hold → Buy
$145 → $163
Dec-13-23 Initiated
Wolfe Research
Outperform
$140
Dec-12-23 Downgrade
BofA Securities
Buy → Neutral
$130 → $133
Nov-17-23 Downgrade
UBS
Buy → Neutral
$163 → $125
Sep-28-23 Initiated
Bernstein
Mkt Perform
$123
Jul-31-23 Downgrade
Evercore ISI
Outperform → In-line
$126 → $124
May-24-23 Reiterated
Wells Fargo
Overweight
$170 → $160
May-24-23 Reiterated
TD Cowen
Outperform
$168 → $145
May-24-23 Reiterated
SVB Securities
Outperform
$170 → $145
May-24-23 Reiterated
Stifel
Hold
$153 → $135
May-24-23 Reiterated
Robert W. Baird
Outperform
$174 → $144
May-24-23 Reiterated
Evercore ISI
Outperform
$150 → $126
May-24-23 Reiterated
Credit Suisse
Outperform
$170 → $160
May-24-23 Reiterated
Citigroup
Neutral
$150 → $130
May-24-23 Reiterated
BofA Securities
Buy
$164 → $144
May-24-23 Reiterated
Barclays
Equal Weight
$140 → $135
Show Previous Ratings
Dec-25-24 11:30AM
Dec-23-24 08:34AM
Dec-20-24 07:44PM
Dec-19-24 01:45PM
Dec-10-24 11:09AM
07:26PM
Loading…
Dec-06-24 07:26PM
Dec-02-24 01:29PM
Nov-26-24 04:24PM
02:58PM
10:16AM
(Thomson Reuters StreetEvents)
09:12AM
02:01AM
Nov-25-24 06:00PM
05:15PM
05:11PM
04:30PM
Loading…
04:30PM
(Associated Press Finance)
04:05PM
09:01AM
Nov-24-24 02:00PM
05:00AM
Nov-22-24 09:00AM
Nov-20-24 04:05PM
11:46AM
09:15AM
08:00AM
Nov-19-24 04:29PM
Nov-14-24 03:02PM
08:00AM
Nov-06-24 08:00AM
Oct-24-24 07:07PM
02:00AM
Loading…
Oct-21-24 02:00AM
Oct-16-24 04:50PM
04:30PM
Oct-09-24 10:15AM
Oct-03-24 09:00PM
Sep-30-24 05:17PM
Sep-23-24 09:30AM
Sep-20-24 11:30AM
11:01AM
09:47AM
06:11AM
Sep-18-24 04:20PM
Sep-12-24 08:44AM
Sep-10-24 05:00PM
Sep-09-24 03:57PM
08:00AM
Sep-02-24 07:33AM
Aug-31-24 01:04AM
Aug-28-24 09:34AM
Aug-26-24 09:15AM
Aug-23-24 03:00PM
Aug-22-24 12:50PM
09:51AM
(Thomson Reuters StreetEvents)
Aug-21-24 09:28PM
08:53PM
06:00PM
05:15PM
04:13PM
(Associated Press Finance)
04:05PM
Aug-20-24 10:29AM
09:01AM
Aug-19-24 10:18AM
Aug-18-24 02:00PM
Aug-16-24 09:15AM
Aug-15-24 08:00AM
Aug-14-24 10:00AM
Aug-12-24 12:58PM
Aug-02-24 08:00AM
Jul-31-24 07:25PM
Jul-30-24 01:01PM
Jul-29-24 09:55AM
Jul-26-24 03:35PM
Jul-25-24 04:09PM
Jul-24-24 07:24AM
Jul-23-24 06:33AM
(Pharmaceutical Technology)
Jul-22-24 11:19AM
10:47AM
09:01AM
Jul-21-24 09:12PM
Jul-19-24 08:46AM
Jul-16-24 04:01PM
Jul-13-24 12:05PM
Jul-01-24 01:04PM
09:01AM
Jun-28-24 11:30AM
Jun-27-24 12:06PM
09:48AM
Jun-26-24 10:07AM
Jun-21-24 03:10AM
Jun-14-24 06:54AM
Jun-06-24 12:01PM
Jun-03-24 11:27AM
11:00AM
May-31-24 07:34PM
May-30-24 04:24PM
02:36PM
12:15PM
(Associated Press Finance)
11:58AM
11:34AM
07:47AM
Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
MCDONNELL PADRAIG President and CEO Sep 27 '24 Sale 150.00 47 7,050 24,071 Sep 30 01:08 PM Grau Dominique Senior Vice President Sep 26 '24 Sale 145.00 9,990 1,448,550 40,011 Sep 27 05:02 PM Grau Dominique Senior Vice President Sep 26 '24 Sale 145.00 5,010 726,450 46,762 Sep 27 05:02 PM MCDONNELL PADRAIG Officer Sep 27 '24 Proposed Sale 150.00 47 7,050 Sep 27 12:19 PM Grau Dominique Officer Sep 26 '24 Proposed Sale 145.00 15,000 2,175,000 Sep 26 02:52 PM MCDONNELL PADRAIG President and CEO Aug 22 '24 Sale 145.00 1,958 283,910 24,118 Aug 23 11:43 AM MCDONNELL PADRAIG Officer Aug 22 '24 Proposed Sale 145.00 1,958 283,910 Aug 22 12:39 PM MCDONNELL PADRAIG President and CEO Jul 26 '24 Sale 140.00 1,958 274,120 26,076 Jul 30 10:42 AM MCDONNELL PADRAIG Officer Jul 26 '24 Proposed Sale 140.00 1,958 274,120 Jul 26 10:56 AM MCDONNELL PADRAIG President and CEO Jun 18 '24 Sale 135.00 1,958 264,330 28,034 Jun 20 06:54 PM Grau Dominique Senior Vice President Jun 10 '24 Sale 133.28 15,000 1,999,262 49,486 Jun 12 10:40 AM MCDONNELL PADRAIG President and CEO Jun 03 '24 Sale 130.00 1,958 254,540 25,185 Jun 05 10:08 AM Binns Philip Senior Vice President Mar 25 '24 Sale 147.54 2,827 417,096 9,997 Mar 27 01:29 PM McMullen Michael R. CEO and President Mar 08 '24 Sale 150.00 52,297 7,844,550 253,909 Mar 12 02:37 PM Gonsalves Rodney V.P., Corporate Controller Mar 07 '24 Sale 149.00 4,828 719,348 21,329 Mar 08 12:05 PM FIELDS HEIDI Director Mar 05 '24 Sale 144.34 1,658 239,316 54,976 Mar 07 10:38 AM Binns Philip Senior Vice President Dec 27 '23 Sale 139.78 2,880 402,566 12,824 Dec 28 01:46 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite